Pharmaceutical - Furiex Pharmaceuticals

Filter

Current filters:

Furiex Pharmaceuticals

Popular Filters

Forest Labs to acquire Furiex Pharma in $1.46 billion deal

29-04-2014

US drugmaker Forest Laboratories has entered into a definitive agreement to acquire Furiex Pharmaceuticals…

eluxadolineForest LaboratoriesFuriex PharmaceuticalsGastro-intestinalsMergers & AcquisitionsPharmaceuticalRoyalty Pharma

Furiex shares double after top-line results of IBS drug eluxadoline in two Phase III studies

Furiex shares double after top-line results of IBS drug eluxadoline in two Phase III studies

05-02-2014

Furiex Pharmaceuticals has announced top-line results from two pivotal Phase III clinical trials evaluating…

FinancialFuriex PharmaceuticalsGastro-intestinalsPharmaceuticalResearchUSA

EMA accepts Takeda's submission of diabetes drug alogliptin

24-05-2012

Japan's largest drugmaker, Takeda Pharmaceuticals (TYO: 4502), says its European subsidiary has received…

alogliptinDiabetesEuropeFuriex PharmaceuticalsPharmaceuticalRegulationTakeda Pharmaceuticals

Furiex Pharma gets rights to Priligy, some of which it sells on to Menarini

15-05-2012

In a two part transaction, USA-based Furiex Pharmaceuticals (Nasdaq: FURX) has entered into an agreement…

ALZA CorpFuriex PharmaceuticalsJanssen PharmaceuticaJohnson & JohnsonLicensingMen's HealthMenariniPharmaceuticalPriligy

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top